Day: February 14, 2022

Not for distribution to U.S. news wire services or dissemination in the United States. TORONTO, Feb. 14, 2022 (GLOBE NEWSWIRE) — Argonaut Gold Inc. (TSX: AR) (“Argonaut” or the “Company”) has announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets, under which the underwriters have agreed to buy on a bought deal basis by way of private placement, 3,400,000 Canadian Exploration Expense (“CEE”) and 13,800,000 Canadian Development Expense (“CDE”) flow-through common shares (collectively, the “Flow-Through Common Shares”) of the Company, at a price of C$2.95 per CEE Flow-Through Common Share and C$2.54 per CDE Flow-Through Common Share, for gross proceeds of approximately C$45 million. In addition, the Company has also granted the underwriters an option,...

Fort Lauderdale, Florida, Feb. 14, 2022 (GLOBE NEWSWIRE) — Splash Beverage Group, Inc. (NYSE American: SBEV) (the “Company” or “Splash Beverage Group”), a portfolio company of leading beverage brands, today announced it has commenced an underwritten public offering. EF Hutton, division of Benchmark Investments, LLC, is acting as the sole book-running manager for the offering. The proposed offering of the common stock described above is being offered by the Company pursuant to a “shelf” registration statement on Form S-3 (File No. 333-259865) filed with the Securities and Exchange Commission (SEC) and declared effective by the SEC on October 8, 2021, and the accompanying prospectus contained therein. The offering is being made only by means of a prospectus supplement and accompanying prospectus. A prospectus supplement...

Montrouge, France, February 14, 2022 DBV Technologies to Present at the 11th Annual SVB Leerink Global Healthcare Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Daniel Tassé, Chief Executive Officer, will present at the 11th Annual SVB Leerink Global Healthcare Conference on Friday, February 18th at 8:40 am ET. A webcast of the presentation will be available on the Investors & Media section of the Company’s website: https://www.dbv-technologies.com/investor-relations/ A replay of the presentation will also be available on DBV Technologies’ website after the event. About DBV TechnologiesDBV Technologies is developing Viaskin™, an investigational proprietary technology platform with broad potential applications in immunotherapy....

Will hold Inaugural Investor Day on March 7 MIAMI, Feb. 14, 2022 (GLOBE NEWSWIRE) — International Money Express, Inc. (NASDAQ: IMXI) (the “Company”), will release Fourth Quarter and Full Year 2021 earnings before the start of trading on Monday, March 7, 2022. Management will host a conference call on March 7, 2022, at 9:00 am ET to discuss the Company’s financial and operating results. The conference call can be accessed as follows:by dialing 1-877-423-9813 (domestic) or 1-201-689-8573 (international) and requesting the International Money Express Fourth Quarter 2021 Earnings Conference Call; or via webcast at https://investors.intermexonline.com/news-events/eventsAn audio replay of the conference call will be available from approximately 12:00 pm ET on March 7, 2022, until 11:59 pm ET on March 21, 2022, and can be accessed...

CLEVELAND, Feb. 14, 2022 (GLOBE NEWSWIRE) — Lincoln Electric Holdings, Inc. (Nasdaq: LECO) today announced that Christopher L. Mapes, Chairman, President and Chief Executive Officer, will speak at the Barclays Industrial Select Conference being held in Miami on Thursday, February 24, 2022, at 9:45 a.m. Eastern Time. The presentation will be webcast and can be accessed on our Investor Relations web site at https://ir.lincolnelectric.com. A replay will also be accessible on our Investor Relations web site. About Lincoln Electric Lincoln Electric is the world leader in the engineering, design, and manufacturing of advanced arc welding solutions, automated joining, assembly and cutting systems, plasma and oxy-fuel cutting equipment, and has a leading global position in brazing and soldering alloys. Lincoln is recognized as the Welding...

– Preliminary Q4 2021 Net Revenue up 19% to Approximately $12.7 Million – – Preliminary FY 2021 Net Revenue up 19% to Approximately $49.6 Million –  – Reed’s Issues 2022 Net Sales Outlook of $59-$62 Million with Approximately 30% Gross Margin – NORWALK, Conn., Feb. 14, 2022 (GLOBE NEWSWIRE) — Reed’s, Inc.® (NASDAQ: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, all-natural ginger beverages, is providing select preliminary unaudited financial results for the three months and full year ended December 31, 2021. “We continued to drive solid growth during our fourth quarter led by strong demand across our portfolio of products, particularly Reed’s Ginger Ale, Ginger Beer, as well as the Virgil’s portfolio,” said Norman E. Snyder, CEO of Reed’s, Inc. “We...

ARCHBOLD, Ohio, Feb. 14, 2022 (GLOBE NEWSWIRE) — Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO) today reported financial results for the 2021 fourth quarter and twelve months ended December 31, 2021. 2021 Fourth Quarter Financial Highlights Include (on a year-over-year basis unless noted):Net income increased 13.4% to a quarterly record of $7.7 million, or $0.59 per basic and diluted share Average shares outstanding increased 16.7% as a result of the Perpetual Federal Savings Bank Acquisition Adjusted net income, excluding one-time tax adjusted acquisition expenses, increased 27.8% to $8.7 million Adjusted earnings, excluding one-time tax adjusted acquisition expenses, increased 10.0% to $0.66 per basic and diluted share Net interest income after provision for loan losses increased 38.7% to a quarterly record of $19.6...

MONTERREY, Mexico, Feb. 14, 2022 (GLOBE NEWSWIRE) — Fomento Económico Mexicano, S.A.B. de C.V. (“FEMSA”) (NYSE: FMX; BMV: FEMSAUBD) today announced that it has modified the start time for its Fourth Quarter and Full Year 2021 Conference Call on Monday, February 28, 2022. The call will now begin at 9:30 AM Eastern Time (8:30 AM Mexico City Time). The call will be hosted by: Daniel Rodriguez Cofré, Chief Executive Officer Francisco Camacho, Chief Corporate Officer Eugenio Garza y Garza, Director of Finance and Corporate Development Juan Fonseca, Director of Investor Relations The quarterly results will be released on February 28 before markets open. To participate in the conference call please dialToll Free US: (800) 289 0720International: +1 (323) 701 0160Conference ID: 6036296 The conference call will be webcast live through streaming...

CAMBRIDGE, Mass., Feb. 14, 2022 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is biologically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™ for the treatment of cancer and autoimmune diseases, today announced plans to report fourth quarter and full year 2021 financial results on Friday, February 25, 2022, before market open. The company will not be hosting a teleconference in conjunction with its financial results press release. About Rubius TherapeuticsRubius Therapeutics is a clinical-stage biopharmaceutical company developing a new class of medicines called Red Cell Therapeutics™. The Company’s proprietary RED PLATFORM® was designed to biologically engineer and culture Red Cell Therapeutics™ that are...